WMT | Weekly | Haru Insights

The Deutsche Bank upgrade of WMT to "Buy" with a $136 price target marks a pivotal shift in analyst sentiment, signaling growing confidence in Walmart’s digital transformation, inflation resilience, and long-term margin expansion potential.
The FDA warning letter over unapproved STI drugs sold on Walmart.com represents a critical regulatory and reputational risk, exposing vulnerabilities in third-party marketplace oversight and raising concerns about compliance, brand integrity, and future regulatory scrutiny.

Walmart’s aggressive digital transformation is delivering tangible results, with e-commerce sales growing 23% year-over-year and its marketplace expanding at a 52% clip, proving its ability to scale high-margin, tech-driven revenue streams.
The company’s strategic pivot toward employee retention through groundbreaking healthcare benefits and career training is not only a cultural win but also a powerful long-term moat that enhances operational stability and reduces turnover costs.
Deutsche Bank’s bullish upgrade and the resulting premarket surge reflect a structural shift in investor perception—WMT is now seen as a high-growth, innovation-led platform, not just a discount retailer, unlocking significant upside potential.
Walmart’s integration of AI into core operations—via Sparky, Express Pickup, and app-enabled shelf lighting—is driving measurable customer engagement, with AI-powered orders seeing 40% higher spending, validating its investment in intelligent retail infrastructure.
The 23% yoy e-commerce growth and 52% marketplace expansion underscore a resilient digital engine that is not just surviving but thriving amid macro headwinds, challenging narratives of retail stagnation.

Walmart Inc. (WMT)[Tv]